Marie-Claire Seeley, PhD, MNurs, RN, discusses standing tests, medication review, and what inflammatory findings may mean for future POTS treatment.
|Articles|October 12, 2020
Pharmacy Times: Week of October 12 Lineup
This week on Pharmacy Times, there are a number of hot topics that we will be posting throughout the week.
Advertisement
This week on Pharmacy Times, there are a number of hot topics that we will be posting throughout the week, including:
- Exclusive content surrounding Women Pharmacist Day on October 12, 2020.
- A video interview with Michael Haydock about the latest news on the COVID-19 vaccine race.
- A podcast episode featuring the Financial Pharmacist Tim Ulbrich about how to handle the financial concerns rooted from the COVID-19 pandemic.
- On Wednesday, Pharmacy Times will publish a white paper outlining how COVID-19 has been a catalyst for innovation and digital transformation.
Advertisement
Related to this article
Researchers found substantial overlap in autonomic symptoms, orthostatic tachycardia, and functional impairment between long COVID and POTS.
BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.
fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.
Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
Advertisement
Advertisement